Incorporation of imipramine into isolated rat peritoneal mast cells in vitro.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000639:Amitriptyline / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D002118:Calcium / Q000494:pharmacology; D002463:Cell Membrane Permeability; D002746:Chlorpromazine / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D003864:Depression, Chemical; D003891:Desipramine / Q000494:pharmacology; D003984:Dibenzazepines / Q000494:pharmacology; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007099:Imipramine / Q000008:administration & dosage / Q000378:metabolism*; D007962:Leukocytes / Q000378:metabolism; D008297:Male; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism*; D009661:Nortriptyline / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology; D013696:Temperature
D003984:Dibenzazepines; D011955:Receptors, Drug; D000639:Amitriptyline; D012701:Serotonin; D012110:Reserpine; D009661:Nortriptyline; D006916:5-Hydroxytryptophan; D003042:Cocaine; D007099:Imipramine; D002118:Calcium; D003891:Desipramine; D002746:Chlorpromazine; D006145:Guanethidine